DK13989A - Anvendelse af tnf og lt til fremstilling af laegemidler. - Google Patents
Anvendelse af tnf og lt til fremstilling af laegemidler.Info
- Publication number
- DK13989A DK13989A DK013989A DK13989A DK13989A DK 13989 A DK13989 A DK 13989A DK 013989 A DK013989 A DK 013989A DK 13989 A DK13989 A DK 13989A DK 13989 A DK13989 A DK 13989A
- Authority
- DK
- Denmark
- Prior art keywords
- tnf
- preparation
- medicinal products
- medicinal
- products
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3801026 | 1988-01-15 | ||
DE3837012A DE3837012A1 (de) | 1988-01-15 | 1988-10-31 | Verwendung von tnf und lt zur herstellung von arzneimitteln |
Publications (2)
Publication Number | Publication Date |
---|---|
DK13989D0 DK13989D0 (da) | 1989-01-13 |
DK13989A true DK13989A (da) | 1989-07-16 |
Family
ID=25863992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK013989A DK13989A (da) | 1988-01-15 | 1989-01-13 | Anvendelse af tnf og lt til fremstilling af laegemidler. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5133960A (da) |
EP (1) | EP0324464B1 (da) |
JP (1) | JPH01216938A (da) |
AU (1) | AU605013B2 (da) |
CA (1) | CA1329540C (da) |
DE (2) | DE3837012A1 (da) |
DK (1) | DK13989A (da) |
ES (1) | ES2036723T3 (da) |
PT (1) | PT89447B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747023A (en) * | 1994-07-01 | 1998-05-05 | Genentech, Inc. | Cancer therapy using lymphotoxin |
WO1997016169A1 (en) * | 1995-11-01 | 1997-05-09 | Chiron Corporation | Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
JP2004528031A (ja) * | 2001-03-14 | 2004-09-16 | セントカー・インコーポレーテツド | 慢性閉塞性肺疾患関連の免疫グロブリン由来タンパク質、組成物、方法および用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ212207A (en) * | 1984-05-31 | 1991-07-26 | Genentech Inc | Recombinant lymphotoxin |
GR851626B (da) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
EP0200748B1 (en) * | 1984-10-15 | 1991-02-06 | Cetus Corporation | Human tumor necrosis factor |
EP0205038A1 (en) * | 1985-05-29 | 1986-12-17 | Suntory Limited | Polypeptide, process for preparing it, microorganism and pharmaceutical use |
JPS61280436A (ja) * | 1986-06-12 | 1986-12-11 | Dainippon Pharmaceut Co Ltd | 利尿剤 |
EP0251037B1 (en) * | 1986-06-20 | 1994-06-15 | Dainippon Pharmaceutical Co., Ltd. | Novel human TNF polypeptide mutants and DNAs encoding said mutants |
US4857314A (en) * | 1986-07-18 | 1989-08-15 | Health Research , Inc. | C-reactive proteins in treatment of animal and human cancers |
-
1988
- 1988-10-31 DE DE3837012A patent/DE3837012A1/de not_active Withdrawn
-
1989
- 1989-01-12 DE DE8989100458T patent/DE58901122D1/de not_active Expired - Lifetime
- 1989-01-12 ES ES198989100458T patent/ES2036723T3/es not_active Expired - Lifetime
- 1989-01-12 US US07/296,144 patent/US5133960A/en not_active Expired - Lifetime
- 1989-01-12 EP EP89100458A patent/EP0324464B1/de not_active Expired - Lifetime
- 1989-01-13 AU AU28472/89A patent/AU605013B2/en not_active Ceased
- 1989-01-13 DK DK013989A patent/DK13989A/da not_active Application Discontinuation
- 1989-01-13 CA CA000588176A patent/CA1329540C/en not_active Expired - Fee Related
- 1989-01-13 PT PT89447A patent/PT89447B/pt not_active IP Right Cessation
- 1989-01-17 JP JP1006080A patent/JPH01216938A/ja active Pending
-
1992
- 1992-03-18 US US07/853,517 patent/US5277903A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA1329540C (en) | 1994-05-17 |
DE3837012A1 (de) | 1989-07-27 |
DE58901122D1 (de) | 1992-05-21 |
DK13989D0 (da) | 1989-01-13 |
US5277903A (en) | 1994-01-11 |
AU605013B2 (en) | 1991-01-03 |
AU2847289A (en) | 1989-07-20 |
EP0324464B1 (de) | 1992-04-15 |
ES2036723T3 (es) | 1993-06-01 |
EP0324464A2 (de) | 1989-07-19 |
EP0324464A3 (en) | 1990-01-31 |
US5133960A (en) | 1992-07-28 |
PT89447B (pt) | 1993-09-30 |
JPH01216938A (ja) | 1989-08-30 |
PT89447A (pt) | 1990-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO903906L (no) | Naeringsmiddelmateriale og fremgangsmaate for fremstilling av dette. | |
DK51493A (da) | Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel | |
IT1231434B (it) | Composizione farmaceutica endovenosa e procedimento per la sua preparazione. | |
DK165730C (da) | Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling | |
NO885453D0 (no) | Silisiumpulver og fremgangsmaate for fremstilling av silisiumpulver. | |
DK95489A (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
DK635988D0 (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
DK514989D0 (da) | Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler | |
DK334989D0 (da) | Antivirale forbindelser og farmaceutiske praeparater med indhold af saadanne. | |
IT8821300A0 (it) | Procedimento di preparazione di morniflumato e analoghi. | |
DK13989D0 (da) | Anvendelse af tnf og lt til fremstilling af laegemidler. | |
NO891630D0 (no) | Fremgangsmaate og anordning for fremstilling av diafragmer. | |
NO881713L (no) | Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere. | |
DK424987A (da) | Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling | |
DK701588A (da) | N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater | |
NO905543D0 (no) | Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer. | |
DK501989D0 (da) | Mikrobiocidt praeparat og dettes fremstilling | |
NO911298D0 (no) | Farmasoeytisk preparat og anvendelse derav. | |
DK670588D0 (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
NO912279D0 (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. | |
DK171089A (da) | Anvendelse af tetrazolderivater til fremstilling af laegemidler | |
DK511687D0 (da) | Farmaceutisk praeparat, samt fremstilling og anvendelse heraf | |
DK68790D0 (da) | Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler | |
DK630089D0 (da) | Anvendelse af aryloxyalkanoler og estere deraf til fremstilling af farmaceutika til behandling af retrovirusinfektioner | |
DK163994C (da) | 1-phenoxy-2-hydroxy-3-aminopropanderivater, farmaceutisk praeparat indeholdende derivaterne og anvendelse af derivaterne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |